Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2000 Sep;54(9):687–691. doi: 10.1136/jech.54.9.687

Trends in Belgian premature avoidable deaths over a 20 year period

P Humblet 1, R Lagasse 1, A Leveque 1
PMCID: PMC1731743  PMID: 10942448

Abstract

STUDY OBJECTIVES—To analyse over a 20 year period the level and trends in the "EC avoidable death indicators".
DESIGN—The Years of Potential Life Lost (YPLL) method applied to curative and preventive avoidable mortality indicators in Belgium for four successive five year periods, countrywide as well as by district, separately for women and men. Ratios of YPLL rates (age standardised) describe changes between 1974-78 and 1990-94.
SETTING—Belgium for the periods 1974-78, 1980-84, 1985-89, 1990-94.
PARTICIPANTS—All avoidable death cases aged 1-64.
MAIN RESULTS—Ratio of YPLL rates indicated a more favourable development between 1974-78 and 1990-94 in the EC avoidable indicators than in all causes premature mortality. The EC avoidable mortality indicators have been assigned to two categories, curative indicators and preventive indicators. The best ratio of YPLL rates was found in curative indicators for men but the largest gains in YPLL rates over the periods come from the "preventive indicators" in men. For women, malignant neoplasm of the breast rose to the first ranked in 1985-1989 and 1990-1994, where it contributed to more years of YPLL loss than motor vehicle accidents, and malignant neoplasm of the trachea, bronchus and lung had risen to the fifth ranked since 1985-89. The order of the top causes for men did not change between 1974 and 1994, except for cirrhosis of liver, which rose from the fifth to the fourth rank. In the particular case of one "preventive indicator", malignant neoplasm of the trachea, bronchus and lung, the regional analysis of time trend between 1974-78 and 1990-94 showed more districts with a favourable development for both men and women in the Flemish region than in Wallonia.
CONCLUSION—The YPLL method combined with the avoidable mortality indicators enabled us to compare the changes of curative and preventive EC avoidable indicators between 1974-78 and 1990-94. In the case of malignant neoplasm of the trachea, bronchus and lung, which is of major concern to the health promotion policies, changes over the periods have widened a "north/south" health contrast.


Keywords: avoidable mortality; YPLL; Belgium

Full Text

The Full Text of this article is available as a PDF (169.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert X., Bayo A., Alfonso J. L., Cortina P., Corella D. The effectiveness of health systems in influencing avoidable mortality: a study in Valencia, Spain, 1975-90. J Epidemiol Community Health. 1996 Jun;50(3):320–325. doi: 10.1136/jech.50.3.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boys R. J., Forster D. P., Józan P. Mortality from causes amenable and non-amenable to medical care: the experience of eastern Europe. BMJ. 1991 Oct 12;303(6807):879–883. doi: 10.1136/bmj.303.6807.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Charlton J. R., Hartley R. M., Silver R., Holland W. W. Geographical variation in mortality from conditions amenable to medical intervention in England and Wales. Lancet. 1983 Mar 26;1(8326 Pt 1):691–696. doi: 10.1016/s0140-6736(83)91981-5. [DOI] [PubMed] [Google Scholar]
  4. Gaizauskiene A., Gurevicius R. Avoidable mortality in Lithuania. J Epidemiol Community Health. 1995 Jun;49(3):281–284. doi: 10.1136/jech.49.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gaizauskiené A., Westerling R. A comparison of avoidable mortality in Lithuania and Sweden 1971-1990. Int J Epidemiol. 1995 Dec;24(6):1124–1131. doi: 10.1093/ije/24.6.1124. [DOI] [PubMed] [Google Scholar]
  6. Humblet P. C., Lagasse R., Moens G. F., Wollast E., van de Voorde H. La mortalité évitable en Belgique. Soc Sci Med. 1987;25(5):485–493. doi: 10.1016/0277-9536(87)90172-9. [DOI] [PubMed] [Google Scholar]
  7. Leveque A., Coppieters Y., Piette D. Belgium and statistics on mortality. Lancet. 1999 Aug 28;354(9180):779–779. doi: 10.1016/S0140-6736(05)76023-2. [DOI] [PubMed] [Google Scholar]
  8. Levi F., Lucchini F., La Vecchia C., Negri E. Trends in mortality from cancer in the European Union, 1955-94. Lancet. 1999 Aug 28;354(9180):742–743. doi: 10.1016/S0140-6736(99)01909-1. [DOI] [PubMed] [Google Scholar]
  9. Mackenbach J. P., Bouvier-Colle M. H., Jougla E. "Avoidable" mortality and health services: a review of aggregate data studies. J Epidemiol Community Health. 1990 Jun;44(2):106–111. doi: 10.1136/jech.44.2.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McDonnell S., Vossberg K., Hopkins R. S., Mittan B. Using YPLL in health planning. Public Health Rep. 1998 Jan-Feb;113(1):55–61. [PMC free article] [PubMed] [Google Scholar]
  11. Ortega A., Puig M. Influence of different upper age limits on the "Years of Potential Life Lost" index. Eur J Epidemiol. 1992 Nov;8(6):875–877. doi: 10.1007/BF00145336. [DOI] [PubMed] [Google Scholar]
  12. Pampalon R. Avoidable mortality in Québec and its regions. Soc Sci Med. 1993 Sep;37(6):823–831. doi: 10.1016/0277-9536(93)90376-f. [DOI] [PubMed] [Google Scholar]
  13. Romeder J. M., McWhinnie J. R. Potential years of life lost between ages 1 and 70: an indicator of premature mortality for health planning. Int J Epidemiol. 1977 Jun;6(2):143–151. doi: 10.1093/ije/6.2.143. [DOI] [PubMed] [Google Scholar]
  14. Rutstein D. D., Berenberg W., Chalmers T. C., Child C. G., 3rd, Fishman A. P., Perrin E. B. Measuring the quality of medical care. A clinical method. N Engl J Med. 1976 Mar 11;294(11):582–588. doi: 10.1056/NEJM197603112941104. [DOI] [PubMed] [Google Scholar]
  15. Westerling R. Can regional variation in "avoidable" mortality be explained by deaths outside hospital? A study from Sweden, 1987-90. J Epidemiol Community Health. 1996 Jun;50(3):326–333. doi: 10.1136/jech.50.3.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Westerling R. Components of small area variation in death rates: a method applied to data from Sweden. J Epidemiol Community Health. 1995 Apr;49(2):214–221. doi: 10.1136/jech.49.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Westerling R. Indicators of "avoidable" mortality in health administrative areas in Sweden 1974-1985. Scand J Soc Med. 1993 Sep;21(3):176–187. doi: 10.1177/140349489302100307. [DOI] [PubMed] [Google Scholar]
  18. Westerling R., Smedby B. The European Community 'avoidable death indicators' in Sweden 1974-1985. Int J Epidemiol. 1992 Jun;21(3):502–510. doi: 10.1093/ije/21.3.502. [DOI] [PubMed] [Google Scholar]
  19. Westerling R. Trends in "avoidable" mortality in Sweden, 1974-1985. J Epidemiol Community Health. 1992 Oct;46(5):489–493. doi: 10.1136/jech.46.5.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Woolhandler S., Himmelstein D. U., Silber R., Bader M., Harnly M., Jones A. A. Medical care and mortality: racial differences in preventable deaths. Int J Health Serv. 1985;15(1):1–22. doi: 10.2190/90P3-LEFF-WNU0-GLY6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES